Global Metabolomics Market $1.

4 Billion by 2021

The global metabolomics market is estimated to reach $1. 4 Billion in 2021, growing at a CAGR of 15.6% from 2017
to 2021, according to a market research report Metabolomics Market Analysis and Forecast 2017-2021, published
by iHealthcareAnalyst, Inc.

The metabolomics market report estimates the market size (Revenue $million - 2014 to 2021) and key market
segments based on detection and separation techniques used, its applications (biomarker discovery, clinical
toxicology, drug assessment, and nutrigenomics), and forecasts growth trends (CAGR% - 2017 to 2021). It also
provides the detailed market landscape and profiles of major competitors in the global metabolomics market
including company overview, financial snapshot, key products, technologies and services offered, and recent trends
in strategic management.

The global metabolomics market research report is divided by geography (regional and country based) into North
America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest
of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Visit the Metabolomics Market Analysis and Forecast 2017-2021 report at

https://www.ihealthcareanalyst.com/report/metabolomics-market/

1. Technique
1.1. Detection Techniques
1.2. Separation Techniques

2. Application
2.1. Biomarker Discovery
2.2. Clinical Toxicology
2.3. Drug Assessment
2.4. Nutrigenomics

3. Company Profiles
3.1. Agilent Technologies Inc.
3.2. Biocrates Life Sciences AG
3.3. Bio-Rad Laboratories, Inc.
3.4. Bruker Corporation
3.5. Human Metabolome Technologies Inc.
3.6. LECO Corporation
3.7. Metabolon Inc.
3.8. Shimadzu Corporation
3.9. ThermoFisher Scientific Inc.
3.10. Waters Corporation

To request Table of Contents and Sample Pages of this report visit:

https://www.ihealthcareanalyst.com/report/metabolomics-market/

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis,
and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting
grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics,
healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view
of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com